用密素治疗创伤后难治性共性过活性的病例报告
Min-Seok Woo1, Seong-Hyun Park1, Jeong-Hyun Hwang1
1Department of Neurosurgery, Kyungpook National University School of Medicine, Daegu, Korea.
Journal of trauma and injury
|September 5, 2025
概括
这份病例报告详细介绍了经过创伤性脑损伤后耐火性心跳过敏症 (PSH) 的成功治疗方法. 布罗莫克里普丁有效地控制了严重的PSH症状,提供了一个新的治疗选择.
科学领域:
- 神经科学
- 神经学
- 创伤护理
背景情况:
- 创伤性脑损伤 (TBI) 可以导致复杂的神经并发症.
- 双交感性过活性 (PSH) 是一种罕见但严重的疾病,其特征是自主性失调.
- 耐火性PSH存在重大管理挑战,通常对标准治疗具有抗性.
研究的目的:
- 描述一个TBI后耐火PSH的独特案例.
- 评估布罗莫克里普丁在治疗严重PSH方面的疗效.
- 强调针对PSH的有针对性的干预措施的重要性.
主要方法:
- 一名19岁的女性患者患有TBI和耐火PSH接受治疗.
- 通过Paroxysmal Sympathetic Hyperactivity-Assessment测量方法确认了PSH的诊断结果.
- 根据症状反应进行剂量调整.
主要成果:
- 布罗莫克里普丁治疗导致PSH发作的频率和严重程度迅速显著降低.
- 在布罗莫克里普丁治疗六天内,PSH症状完全消失.
- 患者在停止治疗后的10个月随访期间保持无症状.
结论:
- 密素是耐火性PSH的有效治疗选择,特别是在TBI后.
- 早期识别和有针对性的治疗对于控制PSH至关重要.
- 在传统的PSH疗法失败时,这种情况支持密素作为一种有价值的替代品.
相关概念视频
Parkinson's Disease: Treatment
375
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
375
Psychosis: Goals of Pharmacotherapy
208
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
208
Mania and Antimanic Drugs: Overview
318
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
318
Cholinergic Antagonists: Therapeutic Uses
866
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
866
COPD: Management Using Bronchodilators and Corticosteroids
300
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
300
REM Sleep Behavior Disorder
378
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
378


